PACER ADVISORS, INC. – Takeda Pharmaceutical Company Limited Transaction History
PACER ADVISORS, INC. portfolio value:
$14.10M
portfolio value
PACER ADVISORS, INC. quarter portfolio value change:
-7.62%
quarter
Takeda Pharmaceutical Company Limited 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +28.52% | 241.32K shares | 2.22M | $12.97 | 1.08M |
| Q2 2022 | share | Increase | +98.44% | 419.79K shares | 5.77M | $14.04 | 846.25K |
| Q1 2022 | share | Increase | +60.59% | 160.89K shares | 2.48M | $14.32 | 426.45K |
| Q4 2021 | share | Increase | +69.72% | 109.09K shares | 1.05M | $13.58 | 265.56K |
| Q3 2021 | share | Decrease | -1.15% | -1.82K shares | -101K | $16.38 | 156.46K |
| Q2 2021 | share | Increase | +19.80% | 26.16K shares | 251K | $16.83 | 158.29K |
| Q1 2021 | share | Decrease | -5.16% | -7.18K shares | -122K | $18.26 | 132.12K |
| Q4 2020 | share | Increase | +337.04% | 107.43K shares | 1.96M | $17.81 | 139.31K |
| Q3 2020 | share | Increase | 0.00% | 31.87K shares | 569K | $17.45 | 31.87K |
| Q1 2020 | share | Decrease | -100.00% | -24.12K shares | -476K | $14.85 | 0 |
| Q4 2019 | share | Increase | +41.71% | 7.1K shares | 183K | $18.8 | 24.12K |
| Q3 2019 | share | Increase | +55.72% | 6.09K shares | 100K | $16.39 | 17.02K |
| Q2 2019 | share | Decrease | -88.28% | -82.37K shares | -1.70M | $16.47 | 10.93K |
| Q1 2019 | share | Decrease | -1.98% | -1.88K shares | 300K | $18.96 | 93.30K |
| Q4 2018 | share | Decrease | -13.39% | -14.72K shares | -748K | $15.34 | 95.19K |
| Q3 2018 | share | Increase | +9.67% | 9.69K shares | 255K | $19.5 | 109.91K |
| Q2 2018 | share | Increase | 0.00% | 100.22K shares | 2.09M | $18.72 | 100.22K |